Aimei Health Technology Co., Ltd. (NASDAQ:AFJK - Get Free Report)'s stock price traded up 0.4% during trading on Friday . The stock traded as high as $11.16 and last traded at $11.15. 50,048 shares were traded during mid-day trading, an increase of 48% from the average session volume of 33,789 shares. The stock had previously closed at $11.10.
Aimei Health Technology Price Performance
The firm's fifty day moving average price is $11.12 and its 200 day moving average price is $10.97.
Hedge Funds Weigh In On Aimei Health Technology
Several large investors have recently made changes to their positions in AFJK. Polar Asset Management Partners Inc. acquired a new position in Aimei Health Technology during the first quarter worth $110,000. Harraden Circle Investments LLC purchased a new stake in shares of Aimei Health Technology during the fourth quarter worth $1,117,000. Quarry LP purchased a new stake in shares of Aimei Health Technology during the fourth quarter worth $1,605,000. Centiva Capital LP grew its holdings in shares of Aimei Health Technology by 1.4% during the fourth quarter. Centiva Capital LP now owns 232,693 shares of the company's stock worth $2,460,000 after buying an additional 3,100 shares in the last quarter. Finally, Berkley W R Corp purchased a new stake in shares of Aimei Health Technology during the fourth quarter worth $4,750,000. 45.58% of the stock is currently owned by institutional investors and hedge funds.
Aimei Health Technology Company Profile
(
Get Free Report)
Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.
Featured Stories
Before you consider Aimei Health Technology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aimei Health Technology wasn't on the list.
While Aimei Health Technology currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
